A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2
Open Access
- 9 January 2012
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 209 (1), 35-50
- https://doi.org/10.1084/jem.20110540
Abstract
The molecular pathophysiology of myeloproliferative neoplasms (MPNs) remains poorly understood. Based on the observation that the transcription factor NF-E2 is often overexpressed in MPN patients, independent of the presence of other molecular aberrations, we generated mice expressing an NF-E2 transgene in hematopoietic cells. These mice exhibit many features of MPNs, including thrombocytosis, leukocytosis, Epo-independent colony formation, characteristic bone marrow histology, expansion of stem and progenitor compartments, and spontaneous transformation to acute myeloid leukemia. The MPN phenotype is transplantable to secondary recipient mice. NF-E2 can alter histone modifications, and NF-E2 transgenic mice show hypoacetylation of histone H3. Treatment of mice with the histone deacetylase inhibitor (HDAC-I) vorinostat restored physiological levels of histone H3 acetylation, decreased NF-E2 expression, and normalized platelet numbers. Similarly, MPN patients treated with an HDAC-I exhibited a decrease in NF-E2 expression. These data establish a role for NF-E2 in the pathophysiology of MPNs and provide a molecular rationale for investigating epigenetic alterations as novel targets for rationally designed MPN therapies.Keywords
This publication has 71 references indexed in Scilit:
- Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce plateletsThe Journal of Experimental Medicine, 2011
- Multi-parameter fluorescence-activated cell sorting and analysis of stem and progenitor cells in myeloid malignanciesBest Practice & Research Clinical Haematology, 2010
- Dual role for the methyltransferase G9a in the maintenance of β-globin gene transcription in adult erythroid cellsProceedings of the National Academy of Sciences of the United States of America, 2009
- Chromatin Architecture and Transcription Factor Binding Regulate Expression of Erythrocyte Membrane Protein GenesMolecular and Cellular Biology, 2009
- NF-E2 overexpression delays erythroid maturation and increases erythrocyte productionBritish Journal of Haematology, 2009
- Identification of a Hierarchy of Multipotent Hematopoietic Progenitors in Human Cord BloodCell Stem Cell, 2007
- Elucidation of the Phenotypic, Functional, and Molecular Topography of a Myeloerythroid Progenitor Cell HierarchyCell Stem Cell, 2007
- Activator-Mediated Recruitment of the MLL2 Methyltransferase Complex to the β-Globin LocusMolecular Cell, 2007
- Various distinctive cytogenetic abnormalities in patients with acute myeloid leukaemia aged 60 years and older express adverse prognostic value: results from a prospective clinical trialBritish Journal of Haematology, 2006
- The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiationProceedings of the National Academy of Sciences of the United States of America, 2006